Hot Topics: Public Health
by Craig Klugman, Ph.D.
Jump to The Resident (Season 2; Episode 10): What would you do doctor?a>;Jump to The Good Doctor (Season 1; Episode 11): Ignoring patient rights; unnecessary risks; crisis planning; Jump to New Amsterdam (Season 1; Episode 11): Superutilizers and racism; Jump to Chicago Med (Season 4; Episode 11): Triage, gestational surrogacy conflicts; ends justifies the means
In the wake of the recent Twitter fight between the National Rifle Association and U.S. physician groups over whether doctors should speak out about firearm policy issues, we argue that professionalism actually requires that doctors take on a leadership role in gun policy debates, even if (in fact, especially if) doing so is politically fraught… Read more
The post Staying in Their Lane: Health Professionals Must Address Gun Violence appeared first on The Hastings Center.Full Article
by Craig Klugman, PhD
This episode revolves around an unidentified pathogen invading the ED when two patients are brought in immediately after their flight from Malaysia lands.…Full Article
…“A group of ethicists, public health and health policy experts, healthcare providers, and lawyers has composed an open letter to President Donald J.
This post can also be found as the November 2018 editorial in the American Journal of Bioethics.
by Alonzo L.…Full Article
by Craig Klugman, Ph.D.
Since January 1, 2018 through November 15, the United States has seen 311 mass shootings that have killed 339 people and injured 1,249.…Full Article
The following post can also be found in the October 2018
issue of the American Journal of Bioethics.
by Ariadne Nichol and David Magnus, Ph.D.…Full Article
A long-anticipated policy change proposed by the Trump administration that would count the use of many federally-subsidized programs against immigrants currently eligible to use them threatens public health and would undermine ethical practice in health professions and systems. The policy would expand the definition of a public charge, someone likely to become dependent on government… Read more
The post Immigrant Health and the Moral Scandal of the “Public Charge” Rule appeared first on The Hastings Center.Full Article
Earlier this month, The Seattle Times published an op-ed by Samuel Browd, medical director of Seattle Children’s Sport Concussion Program, on the risks of brain injury in youth sports. Dr. Browd acknowledged troubling research on the dangers of repetitive brain trauma, but also emphasized that millions of children “have played contact sports without overt symptoms” and… Read more
The post Newspaper Op-Eds Should Disclose Authors’ Industry Ties appeared first on The Hastings Center.Full Article
Freezing fertility or freezing false hope? A content analysis of social egg freezing in U.S. print media
The One Health Approach to Zoonotic Emerging Infectious Diseases
A Radical Approach to Ebola: Saving Humans and Other Animals
Ethical Dilemmas in Protecting Susceptible Subpopulations From Environmental Health Risks: Liberty, Utility, Fairness, and Accountability for Reasonableness
Counseling parents at risk of delivery of an extremely premature infant: Differing strategies
How should we deal with misattributed paternity? A survey of lay public attitudes
Saving Life, Limb, and Eyesight: Assessing the Medical Rules of Eligibility During Armed Conflict
Now is the Time for a Postracial Medicine: Biomedical Research, the National Institutes of Health, and the Perpetuation of Scientific Racism
A Bridge Back to the Future: Public Health Ethics, Bioethics, and Environmental Ethics
We Can and Must Rebuild the Bridges of Interdisciplinary Bioethics
A decision by FamilyTreeDNA, a prominent consumer DNA-testing company, to share data with federal law enforcement means investigators have access to genetic information linked to hundreds of millions of people.
An early pioneer of the rapidly growing market for consumer genetic testing, FamilyTreeDNA confirmed late Thursday that it has granted the FBI access to its vast trove of nearly 2 million genetic profiles.
A preliminary investigation by Guangdong Province in China of He Jiankui, the scientist who created the world’s first gene-edited babies, found that “He had intentionally dodged supervision, raised funds and organized researchers on his own to carry out the human embryo gene-editing intended for reproduction, which is explicitly banned by relevant regulations.”Full Article
Last month, the DNA-testing company 23andMe secured Food and Drug Administration approval for a new screening for gene-based health risks. Along with celiac disease, Alzheimer’s, Parkinson’s, breast cancer and several other medical conditions, the company can now screen clients for two mutations that have been linked to colorectal cancer.
But “F.D.A.-approved” does not necessarily mean “clinically useful.” 23andMe relies on much simpler technology than tests that you’d get at your doctor’s office. As a result, the company’s tests cannot tell you much about your actual risk of developing the diseases in question.
Scientists have long known what causes sickle-cell disease and its devastating effects: a single mutation in one errant gene. But for decades, there has been only modest progress against an inherited condition that mainly afflicts people of African descent.
With advances in gene therapy, that is quickly changing — so much so that scientists have begun to talk of a cure.Full Article
Japan has approved a stem-cell treatment for spinal-cord injuries. The event marks the first such therapy for this kind of injury to receive government approval for sale to patients.
“This is an unprecedented revolution of science and medicine, which will open a new era of healthcare,” says oncologist Masanori Fukushima, head of the Translational Research Informatics Center, a Japanese government organization in Kobe that has been giving advice and support to the project for more than a decade.
But independent researchers warn that the approval is premature. Ten specialists in stem-cell science or spinal-cord injuries, who were approached for comment by Nature and were not involved in the work or its commercialization, say that evidence that the treatment works is insufficient. Many of them say that the approval for the therapy, which is injected intravenously, was based on a small, poorly designed clinical trial.Full Article
Patients receiving new kidneys and livers must take damaging anti-rejection drugs for the rest of their lives. Now researchers hope to train the immune system instead of just tamping it down.Full Article
Vaginal mesh, used to repair and improve weakened pelvic tissues, is implanted in the vaginal wall. It was initially — in 1998 — thought to be a safe and easy solution for women suffering from stress urinary incontinence.
But over time, complications were reported, including chronic inflammation, and mesh that shrinks and becomes encased in scar tissue causing pain, infection and protrusion through the vaginal wall.Full Article
When the Food and Drug Administration approved magnetic resonance imaging (MRI) scanners in 1984, the machines seemed incredible. They offered an inside view of the human body, making it easier to diagnose disease, injuries and physical abnormalities. Today, they’re part of a multibillion-dollar industry: In 2016, 118 out of every 1,000 Americans got an MRI. The use of CT scans was even higher: 245 per 1,000 people in 2016.
But was all of that testing actually necessary?
No way, say physicians from the Mayo Clinic and Stanford University. In a viewpoint article in JAMA, they argue that it’s time to put the brakes on unnecessary and wasted diagnostic imaging.
“There is virtually no evidence that screening of this kind improves overall population health,” write Ohad Oren, Electron Kebebew and John P.A. Ioannidis. But, they admit, it will take a lot to wean Americans off their addiction to medical imaging.Full Article
Are Medicare patients getting better care, or are they being kept out of hospitals to avoid readmission penalties? Are people getting hurt in the process?
There’s no consensus on the answers, as research has produced conflicting results. But the questions intensified recently as two new studies helped stoke skepticism.Full Article